ACTINIUM PHARMACEUTICALS, INC. Cash Equivalents, at Carrying Value
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Cash Equivalents, at Carrying Value of $86.04 million as of 2024-06-30, per its 10-Q filed 2024-08-05.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2024-08-05
- 2024-06-30: Cash Equivalents, at Carrying Value $86.04M.
- 2024-03-31: Cash Equivalents, at Carrying Value $84.06M.
- 2023-12-31: Cash Equivalents, at Carrying Value $76.68M.
- 2023-09-30: Cash Equivalents, at Carrying Value $82.98M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2024-06-30 | $86.04M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $84.06M 10-Q · filed 2024-04-26 |
| 2023-12-31 | $76.68M 10-Q · filed 2024-08-05 |
| 2023-09-30 | $82.98M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $91.28M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $94.52M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $108.91M 10-K · filed 2024-03-29 |
| 2022-09-30 | $111.81M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $116.33M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $72.02M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $77.83M 10-K · filed 2023-03-31 |
| 2021-09-30 | $82.03M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $81.91M 10-Q · filed 2021-07-30 |
| 2020-12-31 | $63.56M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |